[ad_1]
MORE than the sheer scale of logistical needs it may entail, the federal government’s vaccination campaign for the novel coronavirus disease (Covid-19) the next 12 months may be faced with a more overwhelming activity: convincing people of protection and vaccine efficacy. .
The main executor of the federal government’s national coverage of Covid-19, Carlito G. Gálvez, admitted that they already anticipated a lot, particularly in the midst of the last points that haunt the precursors of the so-called vaccine race.
Among the many vaccines that have raised public concerns are those from Chinese-language drug maker Sinovac Biotech Ltd., in addition to the UK one developed by Oxford College and AstraZeneca.
Media around the world reported that Sinovac’s chief executive had admitted in court docket to having bribed certain regulators in China for an earlier vaccine he developed, while AstraZeneca faced scrutiny, significantly in the US. , Attributable to discrepancies in the results of your medical tests.
Currently, each is included in the federal government’s short list of vaccines it is contemplating purchasing for its immunization campaign in the next 12 months.
Intact protocol
GOVERNMENT officials mentioned that they are already aware of the aforementioned points and assured the general public that each producer’s vaccines will not be allowed nationally until they obtain approval from their professional vaccine panel, in addition to the Food and Drug Administration. Medications (FDA).
Regardless of whether they have been simplified, Gálvez assured that the FDA’s evaluation protocols will remain intact to ensure that only protected and efficient vaccines are likely to be allowed in the nation.
And as an added layer of protection, he identified, all producers are currently present in the process software to perform native medical trials.
This, native authorities said, will allow the FDA to witness firsthand the results of the aforementioned vaccine manufacturers.
In case none of the growers get FDA approval, Gálvez mentioned that they produce other options.
He mentioned that they are contemplating purchasing Covid-19 vaccines from at least 17 producers around the world, along with these from Pfizer, Moderna, Russia’s Gamaleya Analysis Institute and China’s Sinopharm.
Information unit
HOWEVER, the difficult half for the federal government is how to convey this information to the target of 25 to 35 million people, who are part of the target beneficiaries of the federal government’s Covid-19 immunization campaign in the next 12 months.
Mayor Arman Dimaguila of Biñan, Laguna, pointed out the psychological hurdle after witnessing Gálvez’s presentation on a web-based discussion forum organized by the Philippines chart and BusinessMirror on Thursday, “Building Hope: Will a Covid-19 Vaccine See the End of the Pandemic?”
Throughout his speech, Gálvez said that the federal government is especially interested in using the Sinovac and Gamaleya vaccines in the preliminary batch of beneficiaries of the federal government’s vaccination campaign for the first quarter of 2021.
“We can have this example in the place where kababayan It will probably be ready for the UK and US vaccine as an alternative, ”Dimaguila said.
“Perhaps with an adequate dissemination of information on the effectiveness of [the vaccine] from China and Russia, maybe we can convince our constituents to get vaccinated with Chinese and Russian vaccines, “added the mayor.
Cavite Governor Jonvic Remulla and Quirino Governor Dakila “Dax” Cua have raised comparable questions about the completion of the LGU facet’s unprecedented immunization mission. Remulla underscored the need to train LGUs to be competent in determining precedence vaccines, with the preparation of the database so early.
Target areas
Gálvez mentioned that an information marketing campaign is already a central element of his Covid-19 vaccination roadmap, which he mentioned will depend on his close coordination with the LGUs involved.
The vaccination czar revealed that they will give priority to the next areas, which are considered epicenters of the pandemic within the nation.
He mentioned that these cover the area of the national capital, Calabarzon, central Luzon.
In addition to being in the middle of the initiative are Davao Metropolis, Cebu Metropolis, Cagayan de Oro, Baguio Metropolis, Bacolod, Iloilo, Zamboanga Metropolis, Tacloban Metropolis and General Santos Metropolis.
Gálvez mentioned that LGUs will play an important role in ensuring that the general public is likely to be continually aware of their vaccination initiatives.
“We will discuss the possibility of how the national government and local government units could work on this unprecedented immunization program,” said Gálvez.
Logistics summit
In addition to coordinating LGU, Gálvez mentioned that they are also considering finalizing their logistics preparation this month.
He mentioned that they will finally hold their logistics summit on December 16, 2020, for the aforementioned function.
Among the many items expected to be addressed at the summit are the installation of the cold chain, the information know-how system, as well as the manpower required for the federal government’s immunization campaign.
“As I said before, the best case scenario is that we will have the vaccine launch, mostly at the end of the second trimester or the middle of the third trimester. [of 2021]”, Gálvez mentioned.
However, as a result of the latest developments, in which some nations such as the United Kingdom and China have already begun restricted use of the Covid-19 vaccine, the federal government may have the ability to additionally begin its immunization campaign in the first quarter of the next 12. months, according to Gálvez.
More than 60 to 70 million Filipinos are expected to benefit from the immunization initiative, which is likely to take place in the next three to five years.
